Article Details

Pfizer, Myovant begin dosing in relugolix contraceptive study

Retrieved on: 2021-04-14 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer, Myovant begin dosing in relugolix contraceptive study. View article details on hiswai:

Excerpt

Pfizer and Myovant have announced that dosing has begun in a Phase III study evaluating the contraceptive efficacy of their relugolix combination ...

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up